A new way to replace a patient's damaged blood vessels may be on its way, as researchers in France are figuring out a way to "knit" new vessels with a collagen-based extracellular matrix. Inserm researcher Nicolas L'Heureux and his colleagues at Inserm/Université de Bordeaux's tissue bioengineering unit published a study in Acta Biomaterialia to … [Read more...] about Is it possible to ‘knit’ replacement blood vessels?
Bluegrass Vascular Technologies recently announced positive results from a clinical study of its Surfacer Inside-Out catheter system. The San Antonio-based company said the trial represents the first independent, multicenter study investigating the applicability of the Surfacer system, which is designed to provide access to the jugular vein to … [Read more...] about Bluegrass Vascular touts results of Surfacer catheter trial
A new clinical trial has shown that the Cefaly migraine treatment device is safe and effective for migraine prevention, according to manufacturer Cefaly Technology. Cefaly is an external trigeminal nerve stimulation device (e-TNS) that is magnetically connected to a self-adhesive electrode placed on the forehead. It sends micro-impulses through … [Read more...] about Trial: Cefaly wearable safe, effective in preventing migraines
A new study has found that use of the Boston Scientific (NYSE:BSX) Watchman left atrial appendage closure (LAAC) device to treat atrial fibrillation costs less than existing and novel anticoagulant drugs over five years. The retrospective study pooled data from the randomized trials of the Marlborough, Mass.-based company’s Watchman device. The … [Read more...] about Study: Boston Sci’s Watchman cheaper than drugs long-term
The Centers for Medicare and Medicaid Services have updated the criteria for hospitals and physicians to begin or continue providing transcatheter aortic valve replacement surgery. The decision gives hospitals and providers more flexibility to meet the CMS requirements for performing TAVR, the agency said Friday. The original National Coverage … [Read more...] about CMS expands TAVR coverage
Only one in five adults can accurately recognize the signs and symptoms of heart failure, according to a new survey commissioned by Abbott (NYSE:ABT). The survey of more than 3,000 Americans revealed a significant gap in awareness of what heart failure is and an understanding of how the disease can be managed. More than six million Americans are … [Read more...] about Survey: Few adults know signs of heart failure